AbbVie Inc. (ABBV.BA)
ARS 20125.0
(0.12%)
ARS 20125.0
(0.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 54.31 Billion USD | -6.44% |
| 2022 | 58.05 Billion USD | 3.3% |
| 2021 | 56.19 Billion USD | 22.69% |
| 2020 | 45.8 Billion USD | 37.69% |
| 2019 | 33.26 Billion USD | 1.57% |
| 2018 | 32.75 Billion USD | 16.08% |
| 2017 | 28.21 Billion USD | 10.06% |
| 2016 | 25.63 Billion USD | 12.16% |
| 2015 | 22.85 Billion USD | 14.52% |
| 2014 | 19.96 Billion USD | 6.23% |
| 2013 | 18.79 Billion USD | 2.23% |
| 2012 | 18.38 Billion USD | 5.37% |
| 2011 | 17.44 Billion USD | 11.55% |
| 2010 | 15.63 Billion USD | 10.02% |
| 2009 | 14.21 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 14.46 Billion USD | 17.48% |
| 2024 Q1 | 12.31 Billion USD | -13.92% |
| 2023 FY | 54.31 Billion USD | -6.44% |
| 2023 Q3 | 13.92 Billion USD | 0.45% |
| 2023 Q2 | 13.86 Billion USD | 13.42% |
| 2023 Q4 | 14.3 Billion USD | 2.69% |
| 2023 Q1 | 12.22 Billion USD | -19.15% |
| 2022 Q2 | 14.58 Billion USD | 7.72% |
| 2022 Q4 | 15.12 Billion USD | 2.09% |
| 2022 FY | 58.05 Billion USD | 3.3% |
| 2022 Q1 | 13.53 Billion USD | -9.06% |
| 2022 Q3 | 14.81 Billion USD | 1.57% |
| 2021 Q4 | 14.88 Billion USD | 3.79% |
| 2021 Q3 | 14.34 Billion USD | 2.74% |
| 2021 Q2 | 13.95 Billion USD | 7.29% |
| 2021 FY | 56.19 Billion USD | 22.69% |
| 2021 Q1 | 13.01 Billion USD | -6.12% |
| 2020 Q1 | 8.61 Billion USD | -0.98% |
| 2020 FY | 45.8 Billion USD | 37.69% |
| 2020 Q3 | 12.9 Billion USD | 23.76% |
| 2020 Q2 | 10.42 Billion USD | 20.95% |
| 2020 Q4 | 13.85 Billion USD | 7.41% |
| 2019 FY | 33.26 Billion USD | 1.57% |
| 2019 Q3 | 8.47 Billion USD | 2.71% |
| 2019 Q4 | 8.7 Billion USD | 2.65% |
| 2019 Q1 | 7.82 Billion USD | -5.74% |
| 2019 Q2 | 8.25 Billion USD | 5.45% |
| 2018 Q2 | 8.27 Billion USD | 4.34% |
| 2018 Q3 | 8.23 Billion USD | -0.51% |
| 2018 FY | 32.75 Billion USD | 16.08% |
| 2018 Q1 | 7.93 Billion USD | 2.52% |
| 2018 Q4 | 8.3 Billion USD | 0.84% |
| 2017 Q2 | 6.94 Billion USD | 6.21% |
| 2017 Q3 | 6.99 Billion USD | 0.73% |
| 2017 Q4 | 7.73 Billion USD | 10.64% |
| 2017 FY | 28.21 Billion USD | 10.06% |
| 2017 Q1 | 6.53 Billion USD | -3.8% |
| 2016 Q3 | 6.43 Billion USD | -0.31% |
| 2016 FY | 25.63 Billion USD | 12.16% |
| 2016 Q4 | 6.79 Billion USD | 5.66% |
| 2016 Q2 | 6.45 Billion USD | 8.29% |
| 2016 Q1 | 5.95 Billion USD | -6.91% |
| 2015 Q4 | 6.4 Billion USD | 7.67% |
| 2015 FY | 22.85 Billion USD | 14.52% |
| 2015 Q1 | 5.04 Billion USD | -7.56% |
| 2015 Q2 | 5.47 Billion USD | 8.63% |
| 2015 Q3 | 5.94 Billion USD | 8.57% |
| 2014 FY | 19.96 Billion USD | 6.23% |
| 2014 Q3 | 5.01 Billion USD | 1.89% |
| 2014 Q4 | 5.45 Billion USD | 8.63% |
| 2014 Q2 | 4.92 Billion USD | 7.96% |
| 2014 Q1 | 4.56 Billion USD | -10.72% |
| 2013 Q2 | 4.69 Billion USD | 8.39% |
| 2013 Q4 | 5.11 Billion USD | 9.73% |
| 2013 FY | 18.79 Billion USD | 2.23% |
| 2013 Q1 | 4.32 Billion USD | -16.84% |
| 2013 Q3 | 4.65 Billion USD | -0.72% |
| 2012 Q2 | 4.49 Billion USD | 7.67% |
| 2012 Q3 | 4.5 Billion USD | 0.33% |
| 2012 Q1 | 4.17 Billion USD | -14.21% |
| 2012 FY | 18.38 Billion USD | 5.37% |
| 2012 Q4 | 5.2 Billion USD | 15.48% |
| 2011 Q3 | 4.4 Billion USD | 3.14% |
| 2011 Q4 | 4.86 Billion USD | 10.33% |
| 2011 FY | 17.44 Billion USD | 11.55% |
| 2011 Q1 | 3.89 Billion USD | 0.0% |
| 2011 Q2 | 4.27 Billion USD | 9.69% |
| 2010 FY | 15.63 Billion USD | 10.02% |
| 2009 FY | 14.21 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|